このアイテムのアクセス数: 320
このアイテムのファイル:
| ファイル | 記述 | サイズ | フォーマット | |
|---|---|---|---|---|
| 40_555.pdf | 401.12 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
| DCフィールド | 値 | 言語 |
|---|---|---|
| dc.contributor.author | 前川た, かし | ja |
| dc.contributor.author | 柏原, 昇 | ja |
| dc.contributor.author | 辻田, 正昭 | ja |
| dc.contributor.author | 森川, 洋二 | ja |
| dc.contributor.author | 早原, 信行 | ja |
| dc.contributor.author | 西島, 高明 | ja |
| dc.contributor.author | 江崎, 和芳 | ja |
| dc.contributor.author | 千住, 将明 | ja |
| dc.contributor.author | 入谷, 純光 | ja |
| dc.contributor.author | 山口, 武津雄 | ja |
| dc.contributor.author | 川村, 正喜 | ja |
| dc.contributor.author | 田中, 寛 | ja |
| dc.contributor.author | 安本, 亮二 | ja |
| dc.contributor.alternative | Maekawa, Takashi | en |
| dc.contributor.alternative | Kashihara, Noboru | en |
| dc.contributor.alternative | Tsujita, Masaaki | en |
| dc.contributor.alternative | Morikawa, Yoji | en |
| dc.contributor.alternative | Hayahara, Nobuyuki | en |
| dc.contributor.alternative | Nishijima, Takaaki | en |
| dc.contributor.alternative | Ezaki, Kazuyoshi | en |
| dc.contributor.alternative | Senju, Masaaki | en |
| dc.contributor.alternative | Iritani, Mitsuaki | en |
| dc.contributor.alternative | Yamaguchi, Mutuo | en |
| dc.contributor.alternative | Kawamura, Masaki | en |
| dc.contributor.alternative | Tanaka, Hiroshi | en |
| dc.contributor.alternative | Yasumoto, Ryoji | en |
| dc.date.accessioned | 2010-05-28T05:08:04Z | - |
| dc.date.available | 2010-05-28T05:08:04Z | - |
| dc.date.issued | 1994-06 | - |
| dc.identifier.issn | 0018-1994 | - |
| dc.identifier.uri | http://hdl.handle.net/2433/115278 | - |
| dc.description.abstract | 酢酸クロルマジノン単独投与(A群)34例, 酢酸クロルマジノン+UFT (B群)36例でrandomized studyを行った。抗腫瘍効果ならびに臨床効果には各項目とも有意差を認めなかったが, 非再燃率ならびに生存率においてはB群がA群より有意に優れていた。副作用はA群が3例, B群が8例で有意差はなかった | ja |
| dc.description.abstract | We carried out a randomized joint study on endocrine therapy and endocrine chemotherapy for prostatic cancer at our department and 17 affiliated institutions. Of 80 patients entered, 39 patients were treated with chlormadinone acetate alone (group A) and 41 patients were treated with chlormadinone acetate in combination with UFT (group B). After excluding 10 inappropriate patients, Stage C was observed in 14 patients in group A and 13 in group B, and stage D in 20 patients in group A and 23 in group B. Side effects were observed in 8.8% (3/34) in group A and 22.2% (8/30) in group B without a significant difference. The anti-tumor effects (response rate) and clinical effects with respect to each item did not significantly differ between the two groups. The non-recurrence rate and survival rate were significantly higher in group B than in group A. These findings suggest the usefulness of endocrine chemotherapy using UFT. | en |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | jpn | - |
| dc.publisher | 泌尿器科紀要刊行会 | ja |
| dc.subject | Prostatic cancer | en |
| dc.subject | Recurrence rate | en |
| dc.subject | UFT | en |
| dc.subject.ndc | 494.9 | - |
| dc.title | 前立腺癌に対する内分泌化学療法の検討 | ja |
| dc.title.alternative | Endocrine chemotherapy for prostatic cancer | en |
| dc.type | departmental bulletin paper | - |
| dc.type.niitype | Departmental Bulletin Paper | - |
| dc.identifier.ncid | AN00208315 | - |
| dc.identifier.jtitle | 泌尿器科紀要 | ja |
| dc.identifier.volume | 40 | - |
| dc.identifier.issue | 6 | - |
| dc.identifier.spage | 555 | - |
| dc.identifier.epage | 561 | - |
| dc.textversion | publisher | - |
| dc.sortkey | 18 | - |
| dc.address | 大阪市立大学医学部泌尿器科腫瘍研究会 | ja |
| dc.address | 大阪市立大学医学部泌尿器科腫瘍研究会 | ja |
| dc.address | 大阪市立大学医学部泌尿器科腫瘍研究会 | ja |
| dc.address | 大阪市立大学医学部泌尿器科腫瘍研究会 | ja |
| dc.address | 大阪市立大学医学部泌尿器科腫瘍研究会 | ja |
| dc.address | 大阪市立大学医学部泌尿器科腫瘍研究会 | ja |
| dc.address | 大阪市立大学医学部泌尿器科腫瘍研究会 | ja |
| dc.address | 大阪市立大学医学部泌尿器科腫瘍研究会 | ja |
| dc.address | 大阪市立大学医学部泌尿器科腫瘍研究会 | ja |
| dc.address | 大阪市立大学医学部泌尿器科腫瘍研究会 | ja |
| dc.address | 大阪市立大学医学部泌尿器科腫瘍研究会 | ja |
| dc.address | 大阪市立大学医学部泌尿器科腫瘍研究会 | ja |
| dc.address | 大阪市立大学医学部泌尿器科腫瘍研究会 | ja |
| dc.address.alternative | the Tumor Research Group, Department of Urology, Osaka City University Medical School | en |
| dc.address.alternative | the Tumor Research Group, Department of Urology, Osaka City University Medical School | en |
| dc.address.alternative | the Tumor Research Group, Department of Urology, Osaka City University Medical School | en |
| dc.address.alternative | the Tumor Research Group, Department of Urology, Osaka City University Medical School | en |
| dc.address.alternative | the Tumor Research Group, Department of Urology, Osaka City University Medical School | en |
| dc.address.alternative | the Tumor Research Group, Department of Urology, Osaka City University Medical School | en |
| dc.address.alternative | the Tumor Research Group, Department of Urology, Osaka City University Medical School | en |
| dc.address.alternative | the Tumor Research Group, Department of Urology, Osaka City University Medical School | en |
| dc.address.alternative | the Tumor Research Group, Department of Urology, Osaka City University Medical School | en |
| dc.address.alternative | the Tumor Research Group, Department of Urology, Osaka City University Medical School | en |
| dc.address.alternative | the Tumor Research Group, Department of Urology, Osaka City University Medical School | en |
| dc.address.alternative | the Tumor Research Group, Department of Urology, Osaka City University Medical School | en |
| dc.address.alternative | the Tumor Research Group, Department of Urology, Osaka City University Medical School | en |
| dc.identifier.pmid | 7521118 | - |
| dcterms.accessRights | open access | - |
| dc.identifier.pissn | 0018-1994 | - |
| dc.identifier.jtitle-alternative | Acta urologica Japonica | la |
| dc.identifier.jtitle-alternative | Hinyokika Kiyo | en |
| 出現コレクション: | Vol.40 No.6 | |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。